NCT00232726View on ClinicalTrials.gov

Clinical Study of Previously Untreated Patients With Malignant Melanoma

PHASE2CompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

September 30, 2005

Study Completion Date

July 31, 2007

Conditions
Malignant MelanomaNeoplasm Metastasis
Interventions
DRUG

CP-4055 (ELACYT)

Trial Locations (3)

15213-2584

University of Pittsburgh, Pittsburgh

NO-0310

The Norwegian Radium Hospital, Oslo

SE-221 85

University Hospital, Lund

Sponsors

Lead Sponsor

Clavis Pharma
All Listed Sponsors
lead

Clavis Pharma

INDUSTRY

NCT00232726 - Clinical Study of Previously Untreated Patients With Malignant Melanoma | Biotech Hunter | Biotech Hunter